Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koumudi Naraparaju

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Research|January 15, 2014
Role of CHD5 in human cancers: 10 years laterVenkatadri Kolla, Tiangang Zhuang, Mayumi Higashi, et al.
Molecular Cancer|August 7, 2015
Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastomaMayumi Higashi, Venkatadri Kolla, Radhika Iyer, et al.
The Biochemical Journal|April 1, 2015
The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complexVenkatadri Kolla, Koumudi Naraparaju, Tiangang Zhuang, et al.
Molecular Cancer Therapeutics|December 25, 2019
Mechanisms of Entrectinib Resistance in a Neuroblastoma Xenograft ModelSuzanne P MacFarland, Koumudi Naraparaju, Radhika Iyer, et al.
Oncotarget|February 20, 2016
Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomasKoumudi Naraparaju, Venkatadri Kolla, Tiangang Zhuang, et al.
Cancer Research|August 26, 2020
Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid TumorsFerro Nguyen, Peng Guan, David T Guerrero, et al.
Cancer Letters|January 23, 2016
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse modelRadhika Iyer, Lea Wehrmann, Rebecca L Golden, et al.
Oncology Reports|April 23, 2020
RET receptor expression and interaction with TRK receptors in neuroblastomasLaura H Tetri, Venkatadri Kolla, Rebecca L Golden, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Research|January 15, 2014
Role of CHD5 in human cancers: 10 years laterVenkatadri Kolla, Tiangang Zhuang, Mayumi Higashi, et al.
Molecular Cancer|August 7, 2015
Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastomaMayumi Higashi, Venkatadri Kolla, Radhika Iyer, et al.
The Biochemical Journal|April 1, 2015
The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complexVenkatadri Kolla, Koumudi Naraparaju, Tiangang Zhuang, et al.
Molecular Cancer Therapeutics|December 25, 2019
Mechanisms of Entrectinib Resistance in a Neuroblastoma Xenograft ModelSuzanne P MacFarland, Koumudi Naraparaju, Radhika Iyer, et al.
Oncotarget|February 20, 2016
Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomasKoumudi Naraparaju, Venkatadri Kolla, Tiangang Zhuang, et al.
Cancer Research|August 26, 2020
Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid TumorsFerro Nguyen, Peng Guan, David T Guerrero, et al.
Cancer Letters|January 23, 2016
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse modelRadhika Iyer, Lea Wehrmann, Rebecca L Golden, et al.
Oncology Reports|April 23, 2020
RET receptor expression and interaction with TRK receptors in neuroblastomasLaura H Tetri, Venkatadri Kolla, Rebecca L Golden, et al.
Pageof 1